Baidu
map

5大生物医学重点专项 获国家拨款12亿

2017-12-15 佚名 医谷

近日,科技部官网发布了14个重点专项2018年度项目申报指南,其中包括了“精准医学研究”、“重大慢性非传染性疾病防控研究”等生物医学领域的5大专项,累计国拨经费总概算约12亿元。



近日,科技部官网发布了14个重点专项2018年度项目申报指南,其中包括了“精准医学研究”、“重大慢性非传染性疾病防控研究”等生物医学领域的5大专项,累计国拨经费总概算约12亿元。

“生物医用材料研发与组织器官修复替代”重点专项2018年度项目申报指南

本专项按照多学科结合、全链条部署、一体化实施的原则,鼓励产、学、研、医联合申报,围绕项目的总体目标,部署前沿科学及基础创新、关键核心技术、产品开发、典型示范4大研究任务,以及涉及前沿科学及基础创新、关键核心技术、产品开发、典型示范等的医用级原材料的研发及产业化、标准和规范研究、临床临床转化研究3项重点任务。2018年将继续围绕前沿科学及基础创新、关键核心技术、产品开发、典型示范4大研究任务部署12个方向,拟支持19个项目,国拨经费约为3亿元。实施周期为2018-2020年。


“数字诊疗装备研发”试点专项2018年度项目申报指南

结合实施方案总体安排以及2016年和2017年立项情况,2018年拟部署其中的20个重点方向,拟支持项目24个,国拨经费总概算约2.3亿元,其中用于典型应用示范类项目的中央财政资金不得超过该专项中央财政资金总额的30%。实施周期为2018-2020年。启动任务包括先进医学成像、先进治疗、诊疗一体化、可靠性与工程化和生物学效应评估等前沿和共性技术创新研究,新型专科超声成像系统等重大装备研发,新服务模式解决方案研究,创新诊疗装备区域应用示范等。同时根据前期部署情况,对未部署完成的医学影像设备可靠性与工程化技术、医用电子仪器评价等方向补充部署,加强对新的成像前沿技术、人工智能新型服务模式解决方案等方向部署。


“重大慢性非传染性疾病防控研究”重点专项2018年度项目申报指南

2018年将在心脑血管疾病、恶性肿瘤、慢阻肺、糖尿病、神经精神疾病防控技术研究、重大慢病综合防控研究、重大慢病支撑平台体系研究及国际合作研究等方向继续部署34个三级指南方向,拟支持项目36个,国拨经费总概算约4.5亿元,实施周期为2018-2020年。


“生殖健康及重大出生缺陷防控研究”重点专项2018年度申报指南

2016-2017年,专项启动两批项目立项,涉及“建立和完善中国人群育龄人口队列和出生人口队列,开展生殖健康相关疾病临床防治研究”、“生殖健康与出生缺陷相关疾病发病机制研究”和“出生缺陷、不孕不育和避孕节育防治技术及产品研发”3个重点任务。结合实施方案总体安排,2018年继续在生殖健康相关疾病临床防治研究、出生缺陷和不孕不育防治技术研发2个重点任务中的4个研究方向部署项目,拟支持项目4个,国拨经费总概算约0.9亿元,其中用于典型应用示范类项目的中央财政资金不得超过该专项中央财政资金总额的30%。实施周期为2018-2020年。


“精准医学研究”重点专项2018年度项目申报指南

2018年启动的项目主要部署新一代临床用生命组学技术研发,精准医学大数据的资源整合、存储、利用与共享平台建设,疾病防诊治方案的精准化研究3个主要任务,拟启动5个重点方向,拟支持项目6个,国拨经费总概算约1.3亿元。实施周期为2018—2020年。


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1719410, encodeId=e6ef1e1941019, content=<a href='/topic/show?id=d970958e600' target=_blank style='color:#2F92EE;'>#重点专项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95876, encryptionId=d970958e600, topicName=重点专项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c65032711327, createdName=zhmscau, createdTime=Sun Sep 23 06:12:00 CST 2018, time=2018-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270167, encodeId=74fe2e016739, content=增加儿童保健项目.是根本, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/30yrQPYKndeHChDiaiaxia9cGlrfibfht87aw13tZ9Uibdql4ibxeovoZJDoBWhQpwsuO2tL8MHicYAbI5Gsa5ic97eBGA/132, createdBy=0ddc2188194, createdName=董海鹏, createdTime=Sun Dec 17 20:57:09 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461475, encodeId=75b914614e594, content=<a href='/topic/show?id=06a069243aa' target=_blank style='color:#2F92EE;'>#生物医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69243, encryptionId=06a069243aa, topicName=生物医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28b96422769, createdName=wolongzxh, createdTime=Sun Dec 17 01:12:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269580, encodeId=12c1269580ef, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Dec 15 12:17:40 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269577, encodeId=fb342695e7cd, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Dec 15 12:15:42 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269575, encodeId=a0842695e528, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Dec 15 12:15:30 CST 2017, time=2017-12-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1719410, encodeId=e6ef1e1941019, content=<a href='/topic/show?id=d970958e600' target=_blank style='color:#2F92EE;'>#重点专项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95876, encryptionId=d970958e600, topicName=重点专项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c65032711327, createdName=zhmscau, createdTime=Sun Sep 23 06:12:00 CST 2018, time=2018-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270167, encodeId=74fe2e016739, content=增加儿童保健项目.是根本, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/30yrQPYKndeHChDiaiaxia9cGlrfibfht87aw13tZ9Uibdql4ibxeovoZJDoBWhQpwsuO2tL8MHicYAbI5Gsa5ic97eBGA/132, createdBy=0ddc2188194, createdName=董海鹏, createdTime=Sun Dec 17 20:57:09 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461475, encodeId=75b914614e594, content=<a href='/topic/show?id=06a069243aa' target=_blank style='color:#2F92EE;'>#生物医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69243, encryptionId=06a069243aa, topicName=生物医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28b96422769, createdName=wolongzxh, createdTime=Sun Dec 17 01:12:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269580, encodeId=12c1269580ef, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Dec 15 12:17:40 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269577, encodeId=fb342695e7cd, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Dec 15 12:15:42 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269575, encodeId=a0842695e528, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Dec 15 12:15:30 CST 2017, time=2017-12-15, status=1, ipAttribution=)]
    2017-12-17 董海鹏

    增加儿童保健项目.是根本

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1719410, encodeId=e6ef1e1941019, content=<a href='/topic/show?id=d970958e600' target=_blank style='color:#2F92EE;'>#重点专项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95876, encryptionId=d970958e600, topicName=重点专项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c65032711327, createdName=zhmscau, createdTime=Sun Sep 23 06:12:00 CST 2018, time=2018-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270167, encodeId=74fe2e016739, content=增加儿童保健项目.是根本, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/30yrQPYKndeHChDiaiaxia9cGlrfibfht87aw13tZ9Uibdql4ibxeovoZJDoBWhQpwsuO2tL8MHicYAbI5Gsa5ic97eBGA/132, createdBy=0ddc2188194, createdName=董海鹏, createdTime=Sun Dec 17 20:57:09 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461475, encodeId=75b914614e594, content=<a href='/topic/show?id=06a069243aa' target=_blank style='color:#2F92EE;'>#生物医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69243, encryptionId=06a069243aa, topicName=生物医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28b96422769, createdName=wolongzxh, createdTime=Sun Dec 17 01:12:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269580, encodeId=12c1269580ef, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Dec 15 12:17:40 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269577, encodeId=fb342695e7cd, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Dec 15 12:15:42 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269575, encodeId=a0842695e528, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Dec 15 12:15:30 CST 2017, time=2017-12-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1719410, encodeId=e6ef1e1941019, content=<a href='/topic/show?id=d970958e600' target=_blank style='color:#2F92EE;'>#重点专项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95876, encryptionId=d970958e600, topicName=重点专项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c65032711327, createdName=zhmscau, createdTime=Sun Sep 23 06:12:00 CST 2018, time=2018-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270167, encodeId=74fe2e016739, content=增加儿童保健项目.是根本, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/30yrQPYKndeHChDiaiaxia9cGlrfibfht87aw13tZ9Uibdql4ibxeovoZJDoBWhQpwsuO2tL8MHicYAbI5Gsa5ic97eBGA/132, createdBy=0ddc2188194, createdName=董海鹏, createdTime=Sun Dec 17 20:57:09 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461475, encodeId=75b914614e594, content=<a href='/topic/show?id=06a069243aa' target=_blank style='color:#2F92EE;'>#生物医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69243, encryptionId=06a069243aa, topicName=生物医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28b96422769, createdName=wolongzxh, createdTime=Sun Dec 17 01:12:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269580, encodeId=12c1269580ef, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Dec 15 12:17:40 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269577, encodeId=fb342695e7cd, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Dec 15 12:15:42 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269575, encodeId=a0842695e528, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Dec 15 12:15:30 CST 2017, time=2017-12-15, status=1, ipAttribution=)]
    2017-12-15 1dd8c52fm63(暂无匿称)

    了解了解.继续关注

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1719410, encodeId=e6ef1e1941019, content=<a href='/topic/show?id=d970958e600' target=_blank style='color:#2F92EE;'>#重点专项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95876, encryptionId=d970958e600, topicName=重点专项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c65032711327, createdName=zhmscau, createdTime=Sun Sep 23 06:12:00 CST 2018, time=2018-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270167, encodeId=74fe2e016739, content=增加儿童保健项目.是根本, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/30yrQPYKndeHChDiaiaxia9cGlrfibfht87aw13tZ9Uibdql4ibxeovoZJDoBWhQpwsuO2tL8MHicYAbI5Gsa5ic97eBGA/132, createdBy=0ddc2188194, createdName=董海鹏, createdTime=Sun Dec 17 20:57:09 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461475, encodeId=75b914614e594, content=<a href='/topic/show?id=06a069243aa' target=_blank style='color:#2F92EE;'>#生物医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69243, encryptionId=06a069243aa, topicName=生物医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28b96422769, createdName=wolongzxh, createdTime=Sun Dec 17 01:12:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269580, encodeId=12c1269580ef, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Dec 15 12:17:40 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269577, encodeId=fb342695e7cd, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Dec 15 12:15:42 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269575, encodeId=a0842695e528, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Dec 15 12:15:30 CST 2017, time=2017-12-15, status=1, ipAttribution=)]
    2017-12-15 Y—xianghai

    学习了新知识

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1719410, encodeId=e6ef1e1941019, content=<a href='/topic/show?id=d970958e600' target=_blank style='color:#2F92EE;'>#重点专项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95876, encryptionId=d970958e600, topicName=重点专项)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c65032711327, createdName=zhmscau, createdTime=Sun Sep 23 06:12:00 CST 2018, time=2018-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270167, encodeId=74fe2e016739, content=增加儿童保健项目.是根本, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/30yrQPYKndeHChDiaiaxia9cGlrfibfht87aw13tZ9Uibdql4ibxeovoZJDoBWhQpwsuO2tL8MHicYAbI5Gsa5ic97eBGA/132, createdBy=0ddc2188194, createdName=董海鹏, createdTime=Sun Dec 17 20:57:09 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461475, encodeId=75b914614e594, content=<a href='/topic/show?id=06a069243aa' target=_blank style='color:#2F92EE;'>#生物医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69243, encryptionId=06a069243aa, topicName=生物医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28b96422769, createdName=wolongzxh, createdTime=Sun Dec 17 01:12:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269580, encodeId=12c1269580ef, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Dec 15 12:17:40 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269577, encodeId=fb342695e7cd, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Dec 15 12:15:42 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269575, encodeId=a0842695e528, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Dec 15 12:15:30 CST 2017, time=2017-12-15, status=1, ipAttribution=)]
    2017-12-15 Y—xianghai

    学习了新知识

    0

Baidu
map
Baidu
map
Baidu
map